机译:用玻璃体和/或亚阈播种的眼科视网膜母细胞瘤的动脉内化疗:2年结果
Ophthalmic Oncology Service Memorial Sloan-Kettering Cancer Center New York NY United States;
Ophthalmic Oncology Service Memorial Sloan-Kettering Cancer Center New York NY United States;
Department of Pediatrics Memorial Sloan-Kettering Cancer Center New York NY United States;
Department of Ophthalmology Mt. Sinai School of Medicine New York NY United States;
Department of Epidemiology and Biostatistics Memorial Sloan-Kettering Cancer Center New York NY;
Ophthalmic Oncology Service Memorial Sloan-Kettering Cancer Center New York NY United States;
Division of Interventional Neuroradiology Department of Radiology Neurosurgery and Neurology;
机译:玻璃体和/或视网膜下播种的眼睛视网膜母细胞瘤的动脉内化疗:2年结果
机译:在先前接受化学治疗后进行大规模和持续性或复发性视网膜下视网膜母细胞瘤种子的二级和三级动脉内化疗:30眼的长期肿瘤控制和全球抢救
机译:动脉内输注单侧视网膜母细胞瘤化疗失败后的无核眼睛:玻璃体植入的组织病理学评估
机译:视网膜母细胞瘤患者的眼液代谢组织及其与组织基因表达研究的相关性
机译:化学疗法治疗晚期视网膜母细胞瘤的临床比较:动脉内和玻璃体内化疗与动脉内和静脉内化疗
机译:动脉内输注单侧视网膜母细胞瘤化疗失败后的无核眼睛:玻璃体植入的组织病理学评估
机译:用玻璃体和/或亚阈播种的眼科视网膜母细胞瘤的动脉内化疗:2年结果